Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Researchers from Shanghai Jiao Tong University and affiliated organizations have published their findings from studies that aimed to investigate the pathogenesis of idiopathic pulmonary fibrosis (IPF) ...

While an imbalance in unadjudicated IPF-related adverse events between the treatment and placebo groups led to the discontinuation of the trial, early evidence of efficacy on the forced vital ...

The characteristic IPF cough presents as persistent ... Nintedanib (Ofev) works by inhibiting multiple tyrosine kinases involved in fibroblast activation and proliferation, key cellular processes ...

Idiopathic Pulmonary Fibrosis (IPF) is a fibrotic lung disease characterized ... IL-11 stimulates lung fibroblast-to-myofibroblast differentiation and triggers cell invasion.

Piezo2 is highly expressed in human lung tissue from patients with IPF and in multiple (different) mouse models of lung fibrosis. Piezo2 is highly expressed in primary human lung fibroblasts in ...